Seeking Alpha

Watson Pharmaceuticals (WPI) confirms it will buy Actavis Group for at least €4.25B euros...

Watson Pharmaceuticals (WPI) confirms it will buy Actavis Group for at least €4.25B euros ($5.60B), in a deal that cements its status as one of the world's biggest suppliers of generic drugs. WPI +5.5% AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|